Figure 1

Combined TRAIL and VPA treatment induced cytotoxicity in head and neck cancer cell lines. (A) FaDu, HN3 and SNU899 were treated with TRAIL (0.5, 1 µg/ml) and/or VPA (2.5, 5, 10, 20 mM) for 24 h. MTT assay was used to measure cell viabilities. (*p < 0.05; **p < 0.01; ***p < 0.001) (B) HN3 cells were treated with TRAIL (0.5 µg/ml) and VPA (5 mM), and then the cells were stained with annexin V-FITC and propidium iodide and analyzed via flow cytometry. (C) Cell death by combination TRAIL and VPA was determined using a light microscope.